315
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study

, , , , , , , , , , , , & show all
Pages 1061-1065 | Received 02 Feb 2015, Accepted 21 Mar 2015, Published online: 21 Apr 2015

References

  • Banhidy F, Acs N, Puho EH, Czeil AE. Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: a population-based case–control study. Congenit Anom 2012;50:115–21
  • Colstrup M, Mathiesen ER, Damm P, et al. Pregnancy in women with type 1 diabetes: have the goals of St Vincent declaration been meet concerning fetal and neonatal complications? J Matern Fetal Neonatal Med 2013;26:1682–90
  • Lapolla A, Dalfrà MG, Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract 2008;80:2–7
  • Lapolla A, Dalfrà MG, DiCianni G, et al., for the Scientific Committee of the GISOGD Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis 2008;18:2–7
  • Jensen DM, Sorensen B, Feilberg-Jorgensen N, et al. Maternal and perinatal outcome in 143 danish women with gestational diabetes mellitus and in 143 controls with a similar risk profile. Diabetic Med 2000;17:281–6
  • Lapolla A, Dalfrà MG, Bonomo M, et al. Gestational diabetes mellitus in Italy: a multicenter study. Scientific Committee of GISOGD Group. Eur J Obstet Gynecol Reprod Biol 2009;145:149–53
  • American Diabetes Association. Preconception care of women with diabetes [Position Statement]. Diabetes Care 2007;30:S26
  • Negrato CA, Montenegro RM Jr, Mattar R, et al. Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian Consensus Statement. Diabetol Metab Syndr 2010;27:5–14
  • Lapolla A, Dalfrà MG, Fedele D. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? Diabetes Metab Res Rev 2005;21:241–52
  • Lambert K, Holt RI. The use of insulin analogues in pregnancy. Diabetes Obes Metab 2013;15:888–900
  • Wyatt JW, Frias JL, Hoyme HE, et al., IONS Study Group. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabetic Med 2005;22:803–7
  • Lapolla A, Dafrà MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008;45:61–6
  • Pettitt DJ, Ospina P, Howard C, et al. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabetic Med 2007;24:1129–35
  • Mathiesen ER, Kinsley B, Amiel SA, et al., Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771–6
  • Hod M, Damm P, Kaaja R, et al., Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186–92
  • Di Cianni G, Torlone E, Lencioni C, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabetic Med 2008;25:993–6
  • Leperch J, Lin J, Hall GC, et al. Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy. Obstet Gynecol Int 2012;2012:649070
  • Lapolla A, DiCianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: a report on 10 type 1 diabetic women. Diabetic Med 2009;26:1179–83
  • Hod M, Mathiesen E, Jovanovic L, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine hagedon in type 1 diabetes. J Matern Fetal Neonatal Med 2014;27:7–13
  • De Felippis MR, Bakaysa DL, Bell MA, et al. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue. J Pharm Sci 1998;87:170–6
  • Hompesch M, Ocheltree SM, Wondmagegnehu ET, et al. Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes. Curr Med Res Opin 2009;25:2679–87
  • Ocheltree SM, Hompesch M, Wondmagegnehu ET, et al. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes. Eur J Endocrinol 2010;163:217–23
  • Colatrella A, Visalli N, Abbruzzese S, et al. Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: maternal and perinatal outcomes. Int J Endocrinol 2013;2013:151975. doi: 10.1155/2013/151975
  • National Institute for Health and Clinical Excellence. Clinical guideline 63. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. London: RCOG Press; 2008
  • ACOG Committee on Practice Bulletins-Obstetrics ACOG Practice Bulletin Gestational Diabetes mellitus. Obstet Gynecol 2013;122(2 Pt 1):405. doi: 10.1097/01.AOG.0000433010.01596.a4
  • Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–73
  • International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82
  • Metzger BE, Coustan DR. Summary and recommendations for the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1998;21:B161–7
  • Huggett AST, Nixon DA. Use of glucose oxidase peroxidase and O-dianisine in the determination of blood and urine glucose. Lancet 1957;II:368–70
  • Mosca A, Lapolla A, Gillery P. Glycemic control in the clinical management of diabetic patients. Clin Chem Lab Med 2013;51:753–66
  • Lepercq J, Taupin P, Dubois-Laforgue D, et al. Heterogeneity of fetal growth in type 1 diabetic pregnancy. Diabetes Metab 2001;27:339–44
  • Bertino E, Di Nicola P, Varalda A, et al. Neonatal growth charts. J Matern Fetal Neonatal Med 2012;25(suppl 1):67–9
  • Lechat MF, Dolk H. Registries of congenital anomalies: EUROCAT. Environ Health Perspect 1993;101:153–7
  • Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993;264:E60–7
  • Kerssen A, de Valk HW, Visser GH. Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care 2007;30:1069–74
  • Lapolla A, Dalfrà MG, Bonomo M, et al. Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 2007;77:465–70
  • Dalfrà MG, Sartore G, DiCianni G, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther 2011;13:853–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.